HUMAN ISLET RESEARCH NETWORK MISSION
To better understand how human beta cells are lost in Type 1 Diabetes and to find innovative strategies to protect or replace functional beta cell mass in diabetic patients.
Our Research
Supporting Collaborative Research since 2014
The Human Islet Research Network (HIRN) was established in 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.
Research Resources
Latest News
HIRN Webinar: “A Roadmap to Restoring Tolerance in Type 1 Diabetes: CAR Tregs & Beyond”
Click HERE to access the YouTube video of the recording. Thursday, August 24, 2023 (1:00 pm Eastern / 10:00 am Pacific) Topics discussed: What role do Tregs play in type 1…
Read MoreNew Awards from RFA-22-009: HIRN Consortium on Targeting and Regeneration (CTAR)
Developing A Platform Technology For β-Cell-Targeted Drug Delivery Justin Pierce Annes*, MD, PhD, Stanford University (U01 DK136965) Development of platforms for beta cell-specific delivery and ligand discovery Amit Choudhary*,…
Read MoreHIRN Webinar: “RNA Process in Metabolic Tissues”
Click HERE to access the YouTube video of the recording. Wednesday, July 12, 2023 (1:00 pm Eastern / 10:00 am Pacific) Topics Discussed: Introduction: RNA processing is an important layer of…
Read MoreConsortia
Independent Research Initiatives
HIRN-OPP
Opportunity Pool Projects
The Human Islet Research Network (HIRN) was established In 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.
